MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$3,007K
EPS
-$1.11
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Research and development
1,833
1,195
1,553
1,541
General and administrative
1,251
1,331
1,180
1,164
Total operating expenses
3,084
2,526
2,733
2,705
Loss from operations
-3,084
-2,526
-2,733
-2,705
Interest income
77
94
59
17
Other (expense) income, net
0
-2
3
151
Net loss
-3,007
-2,434
-2,671
-2,537
Basic EPS
-1.11
-0.96
-0.06
-0.13
Diluted EPS
-1.11
-0.96
-0.06
-0.13
Basic Average Shares
2,706,607
2,533,918
43,042,691
18,868,124
Diluted Average Shares
2,706,607
2,533,918
43,042,691
18,868,124
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$3,007K
(-18.53%↓ Y/Y)
Interest income
$77K
(352.94%↑ Y/Y)
Loss from operations
-$3,084K
(-14.01%↓ Y/Y)
Total operating
expenses
$3,084K
(14.01%↑ Y/Y)
Research and development
$1,833K
(18.95%↑ Y/Y)
General and
administrative
$1,251K
(7.47%↑ Y/Y)
Buy us a coffee
INTENSITY THERAPEUTICS, INC. (INTS)
INTENSITY THERAPEUTICS, INC. (INTS)